Chronic active antibody mediated rejection research hub

Allogeneic adipose tissue-derived Mesenchymal stromal cells for the treatment of chronic-active antibody mediated rejection in Kidney transplant recipients

This study is testing a new treatment for kidney transplant rejection. It uses special cells from body fat to see if they are safe and can help kidneys work better after a transplant, aiming to reduce rejection and improve long-term kidney health.